DigestiveICD-10: K22.7Found in a minority of people with chronic reflux; more common in older men and people with obesity

Barrett's Esophagus

Also known as: Barrett esophagus, Barrett's oesophagus, Columnar-lined esophagus

Barrett's esophagus is a change in the lining of the lower esophagus, the tube that carries food from the mouth to the stomach. After years of exposure to stomach acid from chronic reflux, the normal flat cells are replaced by cells that resemble those of the intestine. This change does not cause symptoms by itself and is usually discovered during an endoscopy done for heartburn. Barrett's esophagus matters because it slightly raises the risk of esophageal adenocarcinoma, a type of cancer. The overall risk for any individual remains low, and regular surveillance endoscopy can catch precancerous changes early, when they can be treated effectively without major surgery.

Last updated November 10, 2026

Understanding Barrett's Esophagus

Barrett's esophagus is a change in the lining of the lower esophagus in which the normal flat squamous cells are replaced by a column-shaped, intestine-like lining called intestinal metaplasia, almost always after years of acid and bile reflux. It is found in roughly 1 to 2 percent of adults in Western countries and in 10 to 15 percent of people who have endoscopy for long-standing reflux symptoms, although many cases are never diagnosed because the change itself causes no symptoms. Men are affected about twice as often as women, the typical age at diagnosis is over 50, and it is more common in white people, in smokers and in those who carry weight around the abdomen. A segment is classed as short if it measures under 3 cm and long if 3 cm or more; most people have short segments, which carry a lower risk.

Repeated reflux injures the squamous lining, and the body repairs it with a tougher, acid-tolerant tissue that is better at resisting acid but worse at keeping its genes in order. Over years, a small minority of that tissue accumulates mutations and moves through a sequence of low-grade dysplasia, high-grade dysplasia and finally esophageal adenocarcinoma. The numbers are reassuring for most people: in a Danish study of more than 11,000 patients followed for a median of five years, Barrett's without dysplasia progressed to cancer at about 0.12 percent per year, or roughly one person in 800 annually. Confirmed low-grade dysplasia raises that to around 0.5 to 1 percent per year, and high-grade dysplasia to about 6 percent per year. The lining very rarely reverts to normal on its own, and most people who develop esophageal adenocarcinoma were never known to have Barrett's, which is why both screening and surveillance exist.

Management rests on two pillars, and no supplement replaces either. The first is acid suppression: the American College of Gastroenterology 2022 guideline recommends a once-daily proton pump inhibitor for everyone with Barrett's, and in the AspECT trial of 2,557 patients followed for nine years, high-dose esomeprazole modestly reduced a combined outcome of death, cancer and high-grade dysplasia compared with low-dose therapy. The second is surveillance endoscopy with biopsies every 1 to 2 cm along the segment: every 5 years for segments under 3 cm without dysplasia and every 3 years for longer ones. When dysplasia is confirmed by a second expert pathologist, endoscopic eradication therapy is offered. In the SURF trial, radiofrequency ablation cut progression from low-grade dysplasia to high-grade dysplasia or cancer from 26.5 percent to 1.5 percent over three years, and in the AIM Dysplasia trial it eradicated high-grade dysplasia in 81 percent of patients compared with 19 percent in the sham group. Ablation is not recommended for Barrett's without dysplasia, because the risk it removes is smaller than the risk of strictures and other complications it introduces.

The honest position on natural approaches is that nothing you can swallow has been shown to reverse Barrett's esophagus or to lower the risk of it becoming cancer. Studies linking higher intake of fruit, vegetables, fiber and antioxidant vitamins to lower risk are observational, and the trials that have tested antioxidant supplements against esophageal cancer in other settings have been disappointing or harmful. Vitamin C, vitamin E, selenium, green tea extract, curcumin, sulforaphane and aloe vera all have laboratory data and no human evidence that they change the lining. Where supplements have a small role is in reflux symptom control alongside, never instead of, a proton pump inhibitor: melatonin and psyllium each have small trials showing fewer heartburn episodes. Aspirin was tested in AspECT and gave a modest additional benefit, mainly when combined with high-dose acid suppression, but it is a prescription-level decision because of bleeding risk. Weight loss and stopping smoking are the two lifestyle measures with real data behind them.

The most common mistake is mistaking symptom relief for the end of the problem. Barrett's does not hurt, and a proton pump inhibitor removes the heartburn that led to the diagnosis, so people stop the tablet, miss the three- or five-year endoscopy, and resurface a decade later with a stricture or a tumor. The lining keeps its cancer risk whether or not you can feel reflux. A close second is the opposite error: reading the word precancerous, demanding ablation of a non-dysplastic segment and accepting a procedure that guidelines do not support. Keep the surveillance date in the calendar, keep the acid suppression going at the lowest dose that controls symptoms, and if you take a PPI for years, ask for a vitamin B12 and a magnesium level every two to three years. New difficulty swallowing, food sticking, vomiting blood or black stools are not things to wait on until the next scheduled scope.

At a Glance

Common symptoms
No symptoms from the Barrett's changes themselves, Long-standing heartburn or acid reflux, often for many years, Regurgitation of food or sour liquid
Main treatments
Long-term proton pump inhibitor medication to control acid reflux and reduce ongoing injury, Regular surveillance endoscopy with biopsies to detect dysplasia early, Endoscopic treatments such as radiofrequency ablation or endoscopic resection to remove areas of dysplasia or early cancer
Category
Digestive · Found in a minority of people with chronic reflux; more common in older men and people with obesity
See a doctor if
Heartburn or reflux occurring several times a week for years, particularly if you are male, over 50, overweight, or a smoker

Symptoms

No symptoms from the Barrett's changes themselves
Long-standing heartburn or acid reflux, often for many years
Regurgitation of food or sour liquid
Difficulty or pain when swallowing
Chest pain not related to the heart
Chronic cough, hoarseness, or sore throat from reflux
Unexplained weight loss or vomiting blood, which require urgent assessment

Causes

  • Chronic gastroesophageal reflux disease (GERD) exposing the esophagus to stomach acid and bile
  • Repeated injury and repair of the esophageal lining leading to a change in cell type
  • Hiatal hernia, which makes reflux more likely
  • Genetic susceptibility, as the condition sometimes clusters in families

Risk Factors

  • Chronic reflux symptoms for five years or more
  • Male sex and age over 50
  • White ethnicity
  • Obesity, particularly fat around the abdomen
  • Current or past smoking
  • A family history of Barrett's esophagus or esophageal cancer

Diagnosis

  • Upper endoscopy, in which a thin camera is passed down the throat to inspect the esophageal lining
  • Biopsies taken from the changed area to confirm the diagnosis under a microscope
  • Grading of any dysplasia (precancerous cell changes) as none, low grade, or high grade
  • Surveillance endoscopy at intervals set by the length of the segment and the biopsy findings
  • Newer options such as swallowable capsule-sponge tests are being used in some centers for screening

Treatment

  • Long-term proton pump inhibitor medication to control acid reflux and reduce ongoing injury
  • Regular surveillance endoscopy with biopsies to detect dysplasia early
  • Endoscopic treatments such as radiofrequency ablation or endoscopic resection to remove areas of dysplasia or early cancer
  • Anti-reflux surgery (fundoplication) for some people with severe reflux not controlled by medication
  • Esophagectomy (surgical removal of part of the esophagus) reserved for advanced cancer
  • Supportive: weight loss, smaller meals, not eating within three hours of lying down, and raising the head of the bed to reduce reflux
  • Supportive: stopping smoking and limiting alcohol, both of which increase cancer risk

Natural remedies for barrett's esophagus: what the evidence says

Ranked by the strength of human evidence for barrett's esophagus specifically. These sit alongside medical care, not in place of it.

  1. Melatonin

    Preliminary evidence

    Melatonin is produced in large amounts by the gut lining and appears to tighten the lower esophageal sphincter and reduce acid output. In a small Egyptian trial of 36 people with reflux disease, 3 mg melatonin nightly, omeprazole 20 mg, or both for 4 to 8 weeks all improved heartburn, with the combination acting fastest. Another trial reported symptom relief in a larger group, but it used a multi-ingredient formula and was not blinded. This is evidence for fewer reflux symptoms, not for any change in the Barrett's lining, and it is not a reason to lower a prescribed PPI dose.

    Studied dose
    3 to 6 mg immediate-release melatonin at bedtime for 4 to 8 weeks, taken with, not instead of, prescribed acid suppression.
    Cautions
    Can cause morning grogginess and vivid dreams; may increase bleeding with warfarin and interacts with fluvoxamine, which raises melatonin levels several-fold. US supplements vary widely from their labeled content, so choose a third-party-verified product.
  2. Psyllium

    Preliminary evidence

    Low dietary fiber is associated with more reflux, probably because fiber binds nitrites that relax the lower esophageal sphincter and speeds stomach emptying. In a Russian trial of 36 people with non-erosive reflux and a low-fiber diet, 5 g of psyllium three times a day for 10 days cut the number of heartburn episodes per week by about half and reduced measured reflux events on esophageal pH monitoring. The trial was short and had no placebo arm, so the evidence is preliminary and applies to reflux symptoms rather than to Barrett's itself.

    Studied dose
    5 g psyllium husk in at least 240 mL of water up to three times daily, taken 2 hours apart from other medicines.
    Cautions
    Must be taken with plenty of water to avoid choking or bowel obstruction; people with difficulty swallowing or esophageal strictures should not use it without advice. It can reduce absorption of levothyroxine, digoxin and some other drugs, and may lower blood sugar slightly in people on diabetes medication.

What matters day to day

  • Lose abdominal weight if you carry it: each 5-unit rise in BMI raises the odds of Barrett's by roughly 35 percent, and waist circumference predicts risk even in people with a normal BMI, because belly fat pushes acid upward.
  • Raise the head of your bed by 6 to 8 inches on blocks or a wedge: a trial in people with nighttime reflux showed the elevated position roughly halved acid exposure time compared with lying flat, something extra pillows do not achieve.
  • Finish your last meal at least 3 hours before lying down: late eating increases nocturnal reflux episodes, and most of the acid exposure that damages the esophagus happens at night.
  • Stop smoking: current smokers with Barrett's have about double the risk of progression to cancer, and smoking is a stronger risk factor for esophageal adenocarcinoma than alcohol.
  • Keep alcohol moderate and avoid it late in the evening: it relaxes the lower esophageal sphincter and worsens nighttime reflux, even though it is not independently linked to Barrett's itself.
  • Book the next surveillance endoscopy before you leave the current one, and keep a copy of your biopsy report: the interval depends on segment length and dysplasia grade, and more than a third of patients fall out of recommended surveillance.

Prevention

  • Treat persistent heartburn rather than ignoring it for years
  • Maintain a healthy weight, especially around the waist
  • Do not smoke
  • Avoid large late-night meals and foods that trigger your reflux
  • Ask your doctor about an endoscopy if you have had reflux for many years and other risk factors
  • Keep to the surveillance schedule once Barrett's has been diagnosed

When to See a Doctor

  • Heartburn or reflux occurring several times a week for years, particularly if you are male, over 50, overweight, or a smoker
  • Difficulty swallowing or food sticking in the chest
  • Unintended weight loss or persistent vomiting
  • Vomiting blood or passing black stools (emergency)
  • Reflux symptoms that need daily medication to control

Frequently Asked Questions

References

  1. Shaheen NJ, Falk GW, Iyer PG, et al.. Diagnosis and management of Barrett's esophagus: an updated ACG guideline. American Journal of Gastroenterology (2022)
  2. Hvid-Jensen F, Pedersen L, Drewes AM, et al.. Incidence of adenocarcinoma among patients with Barrett's esophagus. New England Journal of Medicine (2011)
  3. Phoa KN, van Vilsteren FG, Weusten BL, et al.. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA (2014)
  4. Shaheen NJ, Sharma P, Overholt BF, et al.. Radiofrequency ablation in Barrett's esophagus with dysplasia. New England Journal of Medicine (2009)
  5. Jankowski JAZ, de Caestecker J, Love SB, et al.. Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial. The Lancet (2018)
  6. Fitzgerald RC, di Pietro M, O'Donovan M, et al.. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial. The Lancet (2020)
  7. Kandil TS, Mousa AA, El-Gendy AA, Abbas AM. The potential therapeutic effect of melatonin in gastro-esophageal reflux disease. BMC Gastroenterology (2010)
  8. Morozov S, Isakov V, Konovalova M. Fiber-enriched diet helps to control symptoms and improves esophageal motility in patients with non-erosive gastroesophageal reflux disease. World Journal of Gastroenterology (2018)
  9. National Institute of Diabetes and Digestive and Kidney Diseases. Barrett's Esophagus (2024)View source
  10. MedlinePlus, National Library of Medicine. Barrett's Esophagus (2024)View source

Related Conditions

Evidence-graded guides

Have questions about Barrett's Esophagus?

Ask Mother Nature AI for personalized, evidence-based guidance.

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.